These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38791419)

  • 1. Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on
    Gonçalves J; Pinto S; Carmo F; Silva C; Andrade N; Martel F
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway.
    Chen Z; Wang C; Dong H; Wang X; Gao F; Zhang S; Zhang X
    Mol Med; 2020 Jan; 26(1):14. PubMed ID: 32000660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU.
    Sang J; Tang R; Yang M; Sun Q
    Biomed Res Int; 2020; 2020():9312149. PubMed ID: 32851092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells.
    Risberg K; Redalen KR; Sønstevold L; Bjørnetrø T; Sølvernes J; Ree AH
    BMC Cancer; 2016 Jul; 16():531. PubMed ID: 27461218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
    Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
    Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes.
    Amaral MEA; Nery LR; Leite CE; de Azevedo Junior WF; Campos MM
    Invest New Drugs; 2018 Oct; 36(5):782-796. PubMed ID: 29392539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
    Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
    PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
    Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
    Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:lysine 1:2 in breast, pancreatic and colorectal cancer cell lines.
    Silva C; Correia-Branco A; Andrade N; Ferreira AC; Soares ML; Sonveaux P; Stephenne J; Martel F
    Eur J Pharmacol; 2019 Sep; 859():172533. PubMed ID: 31301308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells.
    Wu Z; Huang M; Gong Y; Lin C; Guo W
    Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):355-361. PubMed ID: 29534162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer.
    Khan N; Jajeh F; Eberhardt EL; Miller DD; Albrecht DM; Van Doorn R; Hruby MD; Maresh ME; Clipson L; Mukhtar H; Halberg RB
    Int J Cancer; 2019 Dec; 145(11):3022-3032. PubMed ID: 31018249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models.
    Morelli MP; Tentler JJ; Kulikowski GN; Tan AC; Bradshaw-Pierce EL; Pitts TM; Brown AM; Nallapareddy S; Arcaroli JJ; Serkova NJ; Hidalgo M; Ciardiello F; Eckhardt SG
    Clin Cancer Res; 2012 Feb; 18(4):1051-62. PubMed ID: 22173548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status.
    Ma R; Xu L; Qu X; Che X; Zhang Y; Fan Y; Li C; Guo T; Hou K; Hu X; Drew L; Shen M; Cheung T; Liu Y
    Br J Cancer; 2018 May; 118(11):1453-1463. PubMed ID: 29755114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.
    García-García C; Rivas MA; Ibrahim YH; Calvo MT; Gris-Oliver A; Rodríguez O; Grueso J; Antón P; Guzmán M; Aura C; Nuciforo P; Jessen K; Argilés G; Dienstmann R; Bertotti A; Trusolino L; Matito J; Vivancos A; Chicote I; Palmer HG; Tabernero J; Scaltriti M; Baselga J; Serra V
    Clin Cancer Res; 2015 Dec; 21(24):5499-5510. PubMed ID: 26272063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
    Liu S; Tang Y; Yan M; Jiang W
    Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
    Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
    Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.
    Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Butyrate Upregulates miR-203 Expression to Exert Anti-Proliferation Effect on Colorectal Cancer Cells.
    Han R; Sun Q; Wu J; Zheng P; Zhao G
    Cell Physiol Biochem; 2016; 39(5):1919-1929. PubMed ID: 27771718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2.
    Agrawal S; Woźniak M; Łuc M; Makuch S; Pielka E; Agrawal AK; Wietrzyk J; Banach J; Gamian A; Pizon M; Ziółkowski P
    Sci Rep; 2019 Nov; 9(1):16647. PubMed ID: 31719636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.